Dear Colleagues,

“Those who were fortunate to wake up this morning in Belgrade may believe that they have accomplished enough in their lives. To insist on more than this would be merely immodest”
(Serbian poet and writer Dusko Radovic).

With these words, we would like to warmly welcome you to Belgrade, Serbia, from September 27-29, 2024 on the occasion of the Serbian Society for Mitochondrial and Free Radical Physiology 2024 meeting “Redox Biology: A Paradigm of the Foundation of Life”.

Belgrade (Serbian: Beograd, meaning “white city”) is the capital of Serbia and one of the oldest cities in Europe. It lies at the confluence of the Sava and Danube rivers, the position that defined Belgrade as the Door to Europe, the meeting point between East and West, North and South. In its 7000-year-old history, our city was demolished more than forty times, each time reborn and resurrected, like the Phoenix. Today, Belgrade unites diversity, creating a unique spirit of time. In the words of another Serbian writer, Momo Kapor: “Belgrade is not even in Belgrade, because Belgrade, in fact, is not a city; it is a metaphor, a way of life, a perspective on things”. We are sure that selecting Belgrade for the Meeting will add the right tone while reflecting scientific presentations in a warm atmosphere.

There are a number of reasons one can say that the 21st century has given birth to a new scientific discipline – Redox Biology. And Redox Biology is also, like any other aspect of science and life, a perspective on things, with the cooperation of opposites in its basis. With a goal. Harmonized in health, out-of-balance in illness. Studying Redox biology: oxidants, antioxidants, redox active molecules and redox regulation is a multilayered endeavor to comprehend the complexity and uniqueness of this regulation. Understanding this complexity will allow for a greater understanding of biology and, life.

This Conference is an attempt to get to know more deeply the core of Redox Biology, the core of life.
With these warm thoughts, Belgrade is waiting to meet you in September 2024.

On behalf of the Organising Committee,

Bato Korac

We are pleased to announce the 8th in our series of meetings on mitochondrial disorders and the search for novel effective therapies.

Mitochondrial disorders have emerged as a major cause of inherited human disease. There is a growing appreciation that new treatments will emerge through collaborations between clinicians, laboratory scientists and the life sciences industry based on a firm understanding of the disease mechanisms. This conference aims to bring these groups together.

The conference will build new partnerships that harness our understanding of the disease mechanisms, accelerating the pace of effective treatments for mitochondrial diseases. This year’s programme will include discussions about recent discoveries on mitochondrial DNA (mtDNA) disorders to develop new therapeutic targets and the latest advances in gene editing and genomic technologies. We will also have panel discussions on how we rally the international community for clinical trial consortia and current opportunities and challenges in clinical trials.

The meeting attracts international participants interested in mitochondrial diseases, working in genomics, biochemistry, pathology and clinical medicine. The conference will bring together leaders in translational mitochondrial medicine and basic science with a programme designed to engage and inspire the next generation of mitochondrial researchers.

The programme will also feature short oral presentations selected from abstracts, posters, poster pitches and networking opportunities. Participants choosing accommodation will stay at Hinxton Hall Conference Centre, Wellcome Genome Campus, to enhance opportunities for interaction after the sessions.

This conference is endorsed by European Society for Mitochondrial Research and Medicine and Mitochondrial Medicine Society.

Mitochondrial disorders have emerged as a major cause of inherited human disease.
There is a growing appreciation that new treatments will emerge through collaborations between clinicians, laboratory scientists and the life sciences industry, based on a firm understanding of the disease mechanisms.
This conference, based on the experience of the GENOMIT consortium, funded by the European Joint Programme on rare diseases, aims to bring these groups together, exploring the most recent advances in term of natural histories, artificial intelligence, clinical trial readiness and emerging treatment options in preclinical and clinical models.

This is an international project addressed to a selected target of medical specialists in Ophthalmology and Neurology, specialized in the diagnosis and therapy of Leber’s disease. The event is projected and supported by an international Faculty and the program will start from a general framework of the pathology and goes on to diagnosis, treatment and scientific research.

Agenda Includes:
Research and clinical care updates
Patient registry and data sharing updates
Updates from our industry partners
Parent story and perspectives